There are 6 papers on refeeding syndrome in aging research: 1 trial and 2 observational studies in people, 2 reviews.
“There was no statistically significant difference in mortality between patients with or without RFS regardless of which criteria were used.”
- Human trial1
- Humans2
Interventions
1Assertive enteral nutrition refeeding protocol
no changein humans1
1 study
Assertive enteral nutrition refeeding protocol
no changein humans1
Assertive enteral nutrition refeeding protocol showed no clear effect on refeeding syndrome in humans (malnourished hospital patients at risk of refeeding syndrome) (17.1% vs 9.3%, p = 0.29).
“Serum phosphate < 0.65 mmol/L was seen in 17.1% in the intervention group and 9.3% in the control group, p = 0.29.”
Human trialmalnourished hospital patients at risk of refeeding syndromen = 85
European geriatric medicine
Effects
1Mortality
no changein humans1
1 study
Mortality
no changein humans1
Refeeding syndrome was not clearly linked with mortality in humans (malnourished hospitalized patients receiving enteral tube feeding).
“There was no statistically significant difference in mortality between patients with or without RFS regardless of which criteria were used.”
Humansmalnourished hospitalized patients receiving enteral tube feedingone-yearn = 85
Clinical nutrition ESPEN
Trial sponsors
1 trial84 people